Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
About clinic
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology was created by order of the Government of Russian Federation.
Center is one of the largest hospitals in Europe. It contains the best achievements of modern medical science, designed to serve the health of children. The center is equipped with the latest medical equipment from the world’s leading manufacturers, and at its sites the most advanced and original technologies in the treatment of hematological and oncological diseases are successfully tested.
Aim of the Center
The aim of the center is to develop and introduce new methods of treatment and medical and social rehabilitation of children with diseases of the blood of the immune system, hemoblastosis, tumors of the nervous system and a number of other diseases associated with the activities of the clinic. The center conducts scientific research at the world level. On the basis of the constant work of a group of scientists from the two countries of Russia and Germany, the Moscow-Berlin protocol for the study of acute lymphoblastic leukemia in children was created.
Dmitry Rogachev National Research Center provides specialized high-tech medical care for children from Russia and foreign countries in a 24-hour and day hospital, as well as in an outpatient clinic. Patients aged from infants to 18-21 years old are being treated for various forms of oncological diseases. One of the priority areas is the treatment of leukemia in children, where the survival rate is 95%. There is no analogue of such treatment in other countries yet.
Hospital performs unique operations on bone marrow cell transplantation from related and unrelated donors living all over the world. More than 200 such operations are carried out annually.
Main directions of scientific and practical activities
- complex therapy of hemoblastosis, brain tumors and solid neoplasms in children, adolescents and young adults;
- high-tech surgery and radiation therapy for all types of cancer;
- transplantation of hematopoietic stem cells in cases of bone marrow insufficiency syndromes, immunodeficiencies, hematopoietic malignancies, oncological and hereditary diseases;
- diagnosis and treatment of immunodeficiency and autoimmune diseases in children;
- diagnosis and treatment of hemorrhagic diseases, thrombophilia, anemia, hereditary blood diseases and other pathological conditions;
- development of molecular biological methods for the diagnosis and treatment of hematological, oncological and immunodeficiency diseases in children;
- development of new methods of treatment for children with congenital and acquired aplasias of hematopoiesis;
- optimization of blood transfusion tactics and study of the peculiarities of procurement, storage and transplantation of hematopoietic stem cells;
- optimization of treatment regimens and improvement of the results of radiation diagnostics and therapy in children;
- molecular biological basis for the regulation of hematopoiesis, pathogenesis of erythron diseases and disorders of iron metabolism in children;
- development of complex methods of therapy for hemostasis disorders;
epidemiology of hematological and oncological diseases in children and adolescents.
